Hematology - European Medical Journal

Continue

Hematology

Filter
1 Aug 2013

Preventing Infections in Higher-Risk Myelodysplastic Syndrome Patients Treated with Hypomethylation Agents

Hypomethylation agents became the standard of care for patients with high-risk myelodysplastic syndrome (MDS). While long-term benefits of azacitidine…
We’ve noticed you’re accessing
from North/South America.